WebNov 14, 2014 · Dr. Phillip Chan, Chief Executive Officer of CytoSorbents, commented "In addition to being a member of our Board of Directors, Alan will serve as the … WebApr 5, 2024 · MONMOUTH JUNCTION, N.J. , April 5, 2024 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO ), a leader in the treatment of life-threatening conditions in …
CTSO Cytosorbents Corp. Company Profile & Executives - WSJ
WebBOARD OF DIRECTORS - Cytosorbents BOARD OF DIRECTORS Al W. Kraus Chairman of the Board Mr. Kraus joined the company in August 2003 as Chief Executive Officer and Director. Mr. Kraus stepped down as CEO at the end of 2008 and was … CytoSorbents operates through its wholly-owned subsidiary, CytoSorbents … Dr. Phillip Chan is the Chief Executive Officer of CytoSorbents Corporation … CytoSorbents Appoints Jiny Kim, MBA to its Board of Directors April 5, 2024 ; March. … Board; Executive Management; Advisors; Our Partners; Intellectual Property; … Date Event Details Presentation Webcast; September 2024: CTC Multicenter … CytoSorbents Corporation is a NASDAQ-traded company (CTSO) with more than … CytoSorb ® is the first specifically approved extracorporeal cytokine adsorber in the … CytoSorbents Corporation and CytoSorbents Medical Inc. 305 College … Technology is the Beneficiary of ~$39.5M in Government Funding. CytoSorbents’ … CytoSorb® is a unique blood purification therapy.The product is currently … WebIndependent Director, CytoSorbents Corp. Edward Raymond Jones is on the board of CytoSorbents Corp. and The Medical Education Institute, Inc. and Medical Director … crystal meth drug testing
CytoSorbents Announces Appointment of New Board …
Webdirectors, each of whom must be determined by the Board to satisfy the independence and experience requirements of the NASDAQ Stock Market (“NASDAQ”), provided that the Committee membership shall be subject to the exemptions afforded issuers under SEC and NASDAQ rules. Specifically, one director who does not meet the independence cr iteria of WebApr 5, 2024 · CytoSorbents Corporation (NASDAQ: CTSO ), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces the appointment of Ms. Jiny Kim, MBA to CytoSorbents’ Board of Directors as a new independent director, effective immediately, for a term expiring at … WebINFORMATION FOR INVESTORS. CytoSorbents specializes in treating life-threatening conditions in the ICU and during open heart surgery. The company is committed to serving the best interests of our patients and … dwyer air flow sensor